scholarly journals Prediction of cancer dependencies from expression data using deep learning

2021 ◽  
Author(s):  
Nitay Itzhacky ◽  
Roded Sharan

Novel deep learning methods for predicting gene dependencies and drug sensitivities from gene expression measurements.

2020 ◽  
Author(s):  
Hryhorii Chereda ◽  
Annalen Bleckmann ◽  
Kerstin Menck ◽  
Júlia Perera-Bel ◽  
Philip Stegmaier ◽  
...  

AbstractMotivationContemporary deep learning approaches show cutting-edge performance in a variety of complex prediction tasks. Nonetheless, the application of deep learning in healthcare remains limited since deep learning methods are often considered as non-interpretable black-box models. Layer-wise Relevance Propagation (LRP) is a technique to explain decisions of deep learning methods. It is widely used to interpret Convolutional Neural Networks (CNNs) applied on image data. Recently, CNNs started to extend towards non-euclidean domains like graphs. Molecular networks are commonly represented as graphs detailing interactions between molecules. Gene expression data can be assigned to the vertices of these graphs. In other words, gene expression data can be structured by utilizing molecular network information as prior knowledge. Graph-CNNs can be applied to structured gene expression data, for example, to predict metastatic events in breast cancer. Therefore, there is a need for explanations showing which part of a molecular network is relevant for predicting an event, e.g. distant metastasis in cancer, for each individual patient.ResultsWe extended the procedure of LRP to make it available for Graph-CNN and tested its applicability on a large breast cancer dataset. We present Graph Layer-wise Relevance Propagation (GLRP) as a new method to explain the decisions made by Graph-CNNs. We demonstrate a sanity check of the developed GLRP on a hand-written digits dataset, and then applied the method on gene expression data. We show that GLRP provides patient-specific molecular subnetworks that largely agree with clinical knowledge and identify common as well as novel, and potentially druggable, drivers of tumor progression. As a result this method could be potentially highly useful on interpreting classification results on the individual patient level, as for example in precision medicine approaches or a molecular tumor board.Availabilityhttps://gitlab.gwdg.de/UKEBpublic/graph-lrphttps://frankkramer-lab.github.io/MetaRelSubNetVis/[email protected]


Processes ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 1466
Author(s):  
Aina Umairah Mazlan ◽  
Noor Azida Sahabudin ◽  
Muhammad Akmal Remli ◽  
Nor Syahidatul Nadiah Ismail ◽  
Mohd Saberi Mohamad ◽  
...  

Data-driven model with predictive ability are important to be used in medical and healthcare. However, the most challenging task in predictive modeling is to construct a prediction model, which can be addressed using machine learning (ML) methods. The methods are used to learn and trained the model using a gene expression dataset without being programmed explicitly. Due to the vast amount of gene expression data, this task becomes complex and time consuming. This paper provides a recent review on recent progress in ML and deep learning (DL) for cancer classification, which has received increasing attention in bioinformatics and computational biology. The development of cancer classification methods based on ML and DL is mostly focused on this review. Although many methods have been applied to the cancer classification problem, recent progress shows that most of the successful techniques are those based on supervised and DL methods. In addition, the sources of the healthcare dataset are also described. The development of many machine learning methods for insight analysis in cancer classification has brought a lot of improvement in healthcare. Currently, it seems that there is highly demanded further development of efficient classification methods to address the expansion of healthcare applications.


2020 ◽  
Vol 26 ◽  
Author(s):  
Xiaoping Min ◽  
Fengqing Lu ◽  
Chunyan Li

: Enhancer-promoter interactions (EPIs) in the human genome are of great significance to transcriptional regulation which tightly controls gene expression. Identification of EPIs can help us better deciphering gene regulation and understanding disease mechanisms. However, experimental methods to identify EPIs are constrained by the fund, time and manpower while computational methods using DNA sequences and genomic features are viable alternatives. Deep learning methods have shown promising prospects in classification and efforts that have been utilized to identify EPIs. In this survey, we specifically focus on sequence-based deep learning methods and conduct a comprehensive review of the literatures of them. We first briefly introduce existing sequence-based frameworks on EPIs prediction and their technique details. After that, we elaborate on the dataset, pre-processing means and evaluation strategies. Finally, we discuss the challenges these methods are confronted with and suggest several future opportunities.


Symmetry ◽  
2020 ◽  
Vol 12 (1) ◽  
pp. 154 ◽  
Author(s):  
Ho Sun Shon ◽  
Erdenebileg Batbaatar ◽  
Kyoung Ok Kim ◽  
Eun Jong Cha ◽  
Kyung-Ah Kim

Recently, large-scale bioinformatics and genomic data have been generated using advanced biotechnology methods, thus increasing the importance of analyzing such data. Numerous data mining methods have been developed to process genomic data in the field of bioinformatics. We extracted significant genes for the prognosis prediction of 1157 patients using gene expression data from patients with kidney cancer. We then proposed an end-to-end, cost-sensitive hybrid deep learning (COST-HDL) approach with a cost-sensitive loss function for classification tasks on imbalanced kidney cancer data. Here, we combined the deep symmetric auto encoder; the decoder is symmetric to the encoder in terms of layer structure, with reconstruction loss for non-linear feature extraction and neural network with balanced classification loss for prognosis prediction to address data imbalance problems. Combined clinical data from patients with kidney cancer and gene data were used to determine the optimal classification model and estimate classification accuracy by sample type, primary diagnosis, tumor stage, and vital status as risk factors representing the state of patients. Experimental results showed that the COST-HDL approach was more efficient with gene expression data for kidney cancer prognosis than other conventional machine learning and data mining techniques. These results could be applied to extract features from gene biomarkers for prognosis prediction of kidney cancer and prevention and early diagnosis.


2019 ◽  
Vol 16 (12) ◽  
pp. 5078-5088 ◽  
Author(s):  
Rahul Shahane ◽  
Md. Ismail ◽  
C. S. R. Prabhu

The gene expression classification and identification from DNA microarray data is efficient technique for cancer diagnosis and prognosis for specific cancer subtypes. DNA microarray technology has great potential to discover information from expression levels of thousands of gene. The collection of significant genes which can improve the accuracy can give proper direction in early diagnosis of cancer. Cancer may be of different subtypes. Cancer detection from microarray gene expression data has major challenge of low sample size, high dimensionality and complexity of the data. There is a need for fast and computationally efficient method to deal with these kind of challenges. Deep Learning has succeeded in numerous fields such as image, video, speech, and text processing. Gene expression analysis is a unique challenge to Deep Learning for various cancer detection and prediction tasks in order to set specific biomarkers for different cancer subtypes. In this paper, we briefly discuss the strengths of different Deep Learning architectures for a cancer detection and prediction of various types of cancer through gene expression analysis.


Sign in / Sign up

Export Citation Format

Share Document